Clinical Trials Directory

Trials / Completed

CompletedNCT03596034

A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

A Study to Characterize Puff Topography With Use of a JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Juul Labs, Inc. · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

A Study to Characterize Puff Topography with Use of a JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

Detailed description

This will be an open label study to evaluate puff topography in adult smokers using a JUUL 5% ENDS. Up to 30 subjects will be enrolled and evaluated on Day 1 and Day 15. The duration of the study is 15 days with up to a 28 days screening window.

Conditions

Interventions

TypeNameDescription
OTHERJUUL 5%, Virginia Tobacco, ENDS productSubjects participate in a 15 day product use period during which subjects will be requested to predominantly use the JUUL 5% product ad libitum as their primary source of nicotine. Subjects will be asked to report their daily use of the JUUL 5% product and CPD throughout the 15 day product use period.

Timeline

Start date
2018-08-09
Primary completion
2018-09-26
Completion
2018-09-26
First posted
2018-07-23
Last updated
2021-06-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03596034. Inclusion in this directory is not an endorsement.